Syncope resident survival guide: Difference between revisions
Rim Halaby (talk | contribs) |
Rim Halaby (talk | contribs) |
||
Line 312: | Line 312: | ||
{{familytree/start}} | {{familytree/start}} | ||
{{familytree | | | | | | {{familytree | | | | | A00 | | | | | | A00= '''Determine the etiology'''}} | ||
{{familytree | |,|-|-|-|+|-|-|-|.| |}} | {{familytree | |,|-|-|-|+|-|-|-|.| |}} | ||
{{familytree | B01 | | | {{familytree | A01 | | A02 | | A03 | A01= '''Cardiovascular syncope'''| A02= '''Reflex Syncope'''| A03= '''[[Orthostatic hypotension]]'''}} | ||
{{familytree | |!| | | |!| | | |!| | }} | |||
{{familytree | B01 | | B02 | | B03 | | B01=<div style="float: left; text-align: left; width: 25em; padding:1em;"> | |||
'''Diagnostic criteria'''<br> | '''Diagnostic criteria'''<br> | ||
❑ [[Arrhythmia]] and cardiac ischemia-related [[syncope]] is diagnosed by [[EKG]] specific findings ([[ESC#Classes of Recommendations|Class I; Level of Evidence: C]]) <br> | ❑ [[Arrhythmia]] and cardiac ischemia-related [[syncope]] is diagnosed by [[EKG]] specific findings ([[ESC#Classes of Recommendations|Class I; Level of Evidence: C]]) <br> | ||
Line 338: | Line 339: | ||
: ❑ [[Q waves]] ([[myocardial infarction]])<br> [[File:Q wave.jpg|200px]] | : ❑ [[Q waves]] ([[myocardial infarction]])<br> [[File:Q wave.jpg|200px]] | ||
: ❑ Bifascicular block <br>[[File:Bifascicular block ECG.png|200px]] </div></div></div> | : ❑ Bifascicular block <br>[[File:Bifascicular block ECG.png|200px]] </div></div></div> | ||
|B02= <div style="float: left; text-align: left; width: 25em; padding:1em;"> | |B02= <div style="float: left; text-align: left; width: 25em; padding:1em;">'''Diagnostic criteria'''<br> | ||
'''Diagnostic criteria'''<br> | |||
❑ Diagnosed when [[syncope]] occurs after standing up and there is documentation of [[orthostatic hypotension]]. ([[ESC#Classes of Recommendations|Class I; Level of Evidence: C]]) | ❑ Diagnosed when [[syncope]] occurs after standing up and there is documentation of [[orthostatic hypotension]]. ([[ESC#Classes of Recommendations|Class I; Level of Evidence: C]]) | ||
---- | ---- | ||
'''Additional findings''' <br> ❑ Ocurrs after prolonged standing <br> ❑ Start of new [[antihypertensive]] drug or dosage change <br> ❑ Presence of [[autonomic neuropathy]] <br> ❑ Prolonged standing <br> ❑ Associated with crowd or hot spaces </div> |B03=<div style="float: left; text-align: left; width: 25em; padding:1em;"> | '''Additional findings''' <br> ❑ Ocurrs after prolonged standing <br> ❑ Start of new [[antihypertensive]] drug or dosage change <br> ❑ Presence of [[autonomic neuropathy]] <br> ❑ Prolonged standing <br> ❑ Associated with crowd or hot spaces </div> |B03=<div style="float: left; text-align: left; width: 25em; padding:1em;">'''Diagnostic criteria'''<br> | ||
'''Diagnostic criteria'''<br> | |||
❑ [[Vasovagal syncope]]: if is precipitated by emotional distress and is associated with typical [[prodome]]. ([[ESC#Classes of Recommendations|Class I; Level of Evidence: C]]). <br> | ❑ [[Vasovagal syncope]]: if is precipitated by emotional distress and is associated with typical [[prodome]]. ([[ESC#Classes of Recommendations|Class I; Level of Evidence: C]]). <br> | ||
❑ Situational [[syncope]]: if occurs during or after specific [[Vasovagal syncope#Triggers|triggers]]. ([[ESC#Classes of Recommendations|Class I; Level of Evidence: C]]).<br> | ❑ Situational [[syncope]]: if occurs during or after specific [[Vasovagal syncope#Triggers|triggers]]. ([[ESC#Classes of Recommendations|Class I; Level of Evidence: C]]).<br> |
Revision as of 19:31, 2 April 2014
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Karol Gema Hernandez, M.D. [2]; Alejandro Lemor, M.D. [3]
Synonyms and keywords: Blacking out; collapse; faint; fainting; loss of consciousness; swoon; unconscious
Syncope Resident Survival Guide Microchapters |
---|
Overview |
Causes |
Classification |
Diagnosis |
Treatment |
Do's |
Don'ts |
Overview
Syncope is the transient loss of consciousness (LOC) due to cerebral hypoperfusion and it is characterized by a rapid onset, a short duration and a spontaneous complete recovery. It is important to identify the cause of syncope and recognize high risk patients with structural heart disease or abnormal ECG findings. The initial management of syncope depends on the etiology of the syncope which can be either reflex, orthostatic hypotension or cardiovascular.
Causes
Life Threatening Causes
Life-threatening causes include conditions which may result in death or permanent disability within 24 hours if left untreated.
Common Causes
- Aortic stenosis
- Arrhythmia
- Medications (vasodilators, diuretics, antiarrhythmics, antipsychotics)
- Orthostatic hypotension
- Vagal stimulation
- Vertebrobasilar insufficiency[2]
Classification
Syncope is classified based on the pathophysiology of the etiology.[3]
Cardiovascular Syncope
- Arrhythmias (bradycardia or tachycardia)
- Structural heart disease
- Drug-induced arrhythmia
Orthostatic Hypotension
- Primary autonomic failure (pure autonomic failure, Parkinson's disease)
- Secondary autonomic failure (diabetes, uremia)
- Drug-induced (alcohol, vasodilators, diuretics)
- Hypovolemia (hemorrhage, diarrhea)
Reflex Syncope
- Vasovagal
- Situational (cough, sneeze, postprandial, post-exercise)
- Carotid sinus hypersensitivity
Diagnosis
First Initial Rapid Evaluation of Suspected Syncope
Shown below is an algorithm depicting the First Initial Rapid Evaluation (FIRE) of suspected syncope.
Identify cardinal signs and symptoms that increase the pretest probability of syncope ❑ Loss of consciousness (LOC) of:
| |||||||||||||||||||||||||||||||||||||||
Identify alarming signs or symptoms ❑ Tachycardia ❑ Hypotension ❑ Loss of consciousness ❑ Severe dyspnea ❑ Hemorrhage ❑ Seizures | |||||||||||||||||||||||||||||||||||||||
Unstable patient | Stable patient | ||||||||||||||||||||||||||||||||||||||
ECG findings | |||||||||||||||||||||||||||||||||||||||
Arrhythmia | Myocardial infarction | Normal EKG | |||||||||||||||||||||||||||||||||||||
Administer: ❑ Aspirin 162-325 mg ❑ Oxygen (2-4 L/min) if satO2 <90% ❑ Beta-blockers (unless contraindicated) ❑ Sublingual nitroglycerin 0.4 mg every 5 min for a total of 3 doses Monitor with a 12-lead EKG all the time Click here for STEMI resident survival guide | Hemorrhage ❑ Manage the hypovolemic state
| Pulmonary embolism Suggestive signs and symptoms: ❑ Dyspnea of sudden onset ❑ Pleuritic chest pain ❑ D-dimer >500 ng/ml ❑ Positive CT pulmonary angiography | |||||||||||||||||||||||||||||||||||||
Complete Diagnostic Approach in Patients with Suspected Syncope
Shown below is an algorithm summarizing the diagnostic approach to syncope based on the 2009 ESC Guidelines for the Diagnosis and Management of Syncope.[3]
Abbreviations: TIA: transient ischemic attack; EEG: electroencephalography; HF: heart failure; AF: atrial fibrillation; SVT: supraventricular tachycardia; VT: ventricular tachycardia; MI: myocardial infarction; BBB: bundle branch block; SCD: sudden cardiac death; CAD: coronary artery disease; ARVC: arrhythmogenic right ventricular cardiomyopathy.
Characterize the symptoms: ❑ Loss of consciousness (LOC)
❑ Prodrome
❑ Chest pain (suggestive of cardiovascular syncope)
❑ Activity prior to LOC: (suggestive of cardiovascular or reflex syncope)
| |||||||||||||||||||||||||||||||||
Inquire about medications intake: ❑ Nitrates | |||||||||||||||||||||||||||||||||
Obtain a detailed past medical history: ❑ Previously healthy
❑ Cardiovascular disease:
❑ Neurological diseases: ❑ Metabolic disorders (diabetes) ❑ Recent trauma | |||||||||||||||||||||||||||||||||
Identify possible triggers: Suggestive of reflex syncope Suggestive of cardiovascular or orthostatic hypotension | |||||||||||||||||||||||||||||||||
Examine the patient:
Vitals
Respiratory Cardiovascular
Neurologic
❑ Glasgow coma scale
| |||||||||||||||||||||||||||||||||
Order labs and tests: ❑ EKG (most important initial test)
❑ Glucose (rule out hypoglycemia)
| |||||||||||||||||||||||||||||||||
Confirm diagnosis of syncope Must have this 3 characteristics: ❑ Short duration, AND ❑ Rapid onset, AND ❑ Complete spontaneous recovery | |||||||||||||||||||||||||||||||||
Syncope | Non-syncopal LOC | ||||||||||||||||||||||||||||||||
Known etiology | Unknown etiology | Consider additional tests ❑ Stool guaiac test (rule out GI bleeding) ❑ Blood and urine toxicology tests (rule out intoxication) | |||||||||||||||||||||||||||||||
Determine the etiology: ❑ Cardiovascular
❑ Reflex
| Determine if there are any high risk criteria: ❑ Severe structural heart disease ❑ CAD ❑ Clinical or ECG features suggesting arrhythmic syncope ❑ Important comorbidities
| Consider alternative diagnoses:
| |||||||||||||||||||||||||||||||
High risk | Low risk | ||||||||||||||||||||||||||||||||
❑ Immediate in-hospital monitoring (in bed or telemetry) to look for abnormalities suggestive of arrhythmic syncope (Class I; Level of Evidence: B) | |||||||||||||||||||||||||||||||||
Recurrent episodes of syncope ❑ Order a Holter if > 1 episode/week (Class I; Level of Evidence: B) ❑ Order external loop recorder (ELR) if interval between episodes < 4 weeks (Class IIa; Level of Evidence: B) ❑ Perform carotid sinus massage in patients > 40 years with uncertain syncopal etiology (Class I; Level of Evidence: B)
| Single episode of syncope | ||||||||||||||||||||||||||||||||
In case of suspicion of structural heart disease: ❑ Order an echocardiography (Class I; Level of Evidence: B) | Is any of the following high risk setting present? ❑ Potential risk of physical injury ❑ Occupational implications | ||||||||||||||||||||||||||||||||
Presence of structural heart disease | Absence of structural heart disease | Yes | No | ||||||||||||||||||||||||||||||
❑ Treat accordingly | Perform a tilt test (Class I; Level of Evidence: B) | No further investigation | |||||||||||||||||||||||||||||||
Diagnostic criteria ❑ Reflex syncope: induction of hypotension or bradycardia with reproduction of syncope (Class I; Level of Evidence: B) ❑ Orthostatic hypotension: induction of progressive orthostatic hypotension with or without symptoms (Class I; Level of Evidence: B) | |||||||||||||||||||||||||||||||||
Treatment
Therapeutic Algorithm in Patients with Confirmed Syncope
Shown below is an algorithm summarizing the therapeutic approach to syncope based on the 2009 ESC Guidelines for the Diagnosis and Management of Syncope. [3]
Abbreviations: AF: Atrial fibrillation; SVT: Supraventricular tachycardia; VT: Ventricular tachycardia; MI: Myocardial infarction; BBB: Bundle branch block.
Determine the etiology | |||||||||||||||||||||||||
Cardiovascular syncope | Reflex Syncope | Orthostatic hypotension | |||||||||||||||||||||||
Diagnostic criteria Additional findings
❑ Family history of unexplained sudden death Abnormal EKG findings
| Diagnostic criteria ❑ Diagnosed when syncope occurs after standing up and there is documentation of orthostatic hypotension. (Class I; Level of Evidence: C) Additional findings ❑ Ocurrs after prolonged standing ❑ Start of new antihypertensive drug or dosage change ❑ Presence of autonomic neuropathy ❑ Prolonged standing ❑ Associated with crowd or hot spaces | Diagnostic criteria ❑ Vasovagal syncope: if is precipitated by emotional distress and is associated with typical prodome. (Class I; Level of Evidence: C). Additional findings ❑ History of recurrent syncope ❑ After unpleasant sight, smell, sound or pain ❑ Associated to nausea or vomit ❑ Prolonged standing ❑ Associated with crowd or hot spaces ❑ Head rotation or pressure to carotid sinus ❑ After exertion ❑ Postprandial | |||||||||||||||||||||||
Treatment depends on the cause of the arrhythmia: ❑ Schedule for cardiac pacing surgery in patients with:
❑ Schedule for catheter ablation in patients with:
❑ Administer antiarrhythmic drug therapy in patients with: ❑ Schedule for implantable cardioverter defibrillator surgery in patients with:
| ❑ Adequate hydration and salt intake (Class I; Level of Evidence: C) ❑ Adjunctive therapy if needed: Contraindicated in severe heart disease, acute renal failure, pheochromocytoma, severe hypertension or thyrotoxicosis
❑ Head-up tilt sleeping (>10 °) to increase fluid volume may be indicated (Class IIb; Level of Evidence: C) | ❑ Explain diagnosis and provide reassurance (Class I; Level of Evidence: C) ❑ Explain risk of recurrence and avoidance of triggers (Class I; Level of Evidence: C) ❑ Isometric physical counterpressure maneuvers (PCM) in patients with prodrome(Class I; Level of Evidence: B):
❑ Cardiac pacing should be considered in:
| |||||||||||||||||||||||
Do's
- Tilt testing should be considered to discriminate between reflex syncope and OH (Class IIa; Level of Evidence: C).
- Perform tilt testing if the cause of syncope is a psychiatric disease (Class IIb; Level of Evidence: C).
- Tilt testing may be considered for differentiating syncope with jerking movements from epilepsy (Class IIb; Level of Evidence: C).
- If syncope happened after standing up position, there should be documentation with active standing or tilt testing in order to diagnose orthostatic hypotension.
- If multiple unexplained falls; perform tilt testing (Class IIb; Level of Evidence: C).
- Consider implantable loop recorder before embarking on cardiac pacing in patients with suspected or confirmed reflex syncope presenting with frequent or traumatic syncopal episodes.
- Evaluate neurologically if syncope is due to autonomic failure, to evaluate underlying disease (Class I; Level of Evidence: C).
- Perform exercise testing in patients who experiences syncope during or after exertion (Class I; Level of Evidence: C).
Don'ts
- Don't perform carotid sinus massage in patients with previous TIA or stroke within the past 3 months and in patients with carotid sinus bruits (except if carotid sinus Doppler studies excluded significant stenosis) (Class III; Level of Evidence: C).
- Don't use tilt testing for assessment of treatment. (Class III; Level of Evidence: B).
- Don't perform isoproterenol tilt test in patients with ischemic heart disease (Class III; Level of Evidence: C).
- Don't use adenosine stress test as a diagnostic test to select patients for cardiac pacing, owing to lack of correlation with spontaneous syncope (Class III; Level of Evidence: B).
- Don't perform electrophysiologic study if there is already indication for implantable cardioverter defibrillator in patients with ischemic heart with suspected arrhythmic cause.
- Don't perform electrophysiologic study in patients with normal EKG, no heart disease and no palpitations unless non-syncopal LOC is suspected (Class III; Level of Evidence: B).
- Don't give beta blockers for reflex syncope (Class III; Level of Evidence: A).
References
- ↑ Khoo, C.; Chakrabarti, S.; Arbour, L.; Krahn, AD. (2013). "Recognizing life-threatening causes of syncope". Cardiol Clin. 31 (1): 51–66. doi:10.1016/j.ccl.2012.10.005. PMID 23217687. Unknown parameter
|month=
ignored (help) - ↑ Kapoor, WN. (2000). "Syncope". N Engl J Med. 343 (25): 1856–62. doi:10.1056/NEJM200012213432507. PMID 11117979. Unknown parameter
|month=
ignored (help) - ↑ 3.0 3.1 3.2 Task Force for the Diagnosis and Management of Syncope. European Society of Cardiology (ESC). European Heart Rhythm Association (EHRA). Heart Failure Association (HFA). Heart Rhythm Society (HRS). Moya A; et al. (2009). "Guidelines for the diagnosis and management of syncope (version 2009)". Eur Heart J. 30 (21): 2631–71. doi:10.1093/eurheartj/ehp298. PMC 3295536. PMID 19713422 Check
|pmid=
value (help).